NCT06880770Phase 3Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

Study sponsor: Arrowhead Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2029-03Estimated

Enrollment · participants288Estimated

Source updated2026-09-21Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2025-11-19 · 1 field changed

Planned enrollment increased by 148 participants

− Before

~~140 participants (planned)~~

+ After

288 participants (planned)

Check registry source